Skip to main content

Table 3 Table showing localisation of metastasis, pathologic and treatment characteristics and outcome of patients with metastatic disease at presentation.

From: Outcome of recurrent and metastatic small cell carcinoma of the bladder

Localisation of metastasis

Histology (Mixed or pure SmCC)

Treatment

Response

Survival (months)

Death

Liver and Lung and Mediastinum

Mixed

CT (22EP)

PR > 70%

51.8

no

Lung and bone

Pure

CT (4EP) + RT (Y 45 Gy) + RT in the bladder (24 Gy).

PR < 50%

11.7

yes

Bone

Pure

none

NA

1

yes

  1. SmCC = small cell carcinoma; CNS = central nervous system; RP = retroperitoneal; EP = etoposide and cisplatin; G = gemcitabine; GC = gemcitabine plus cisplatin; MVAC = methotrexate, vinblastine, doxorubicin and cisplatin; MTX = methotrexate; CT = chemotherapy; RT = radiotherapy; Y = Y field radiotherapy; PR = partial response; NA = not applicable